Cortalix is a startup based in the Netherlands, most recent round Seed, 1 tracked investor.
Based in the Netherlands, Cortalix is a startup founded in 2023. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Cortalix develops synthetic single-domain antibody platforms for PET imaging diagnostics, targeted radiotherapeutics, and CAR-T immunotherapies, offering services from discovery to preclinical applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.